If it's a diversified healthcare business you're looking for, with a strong dividend history and a track record of delivering enviable balance sheet and shareholder returns, AbbVie fits the bill on all counts. Supply chain disruptions and inflation have weighed on Kimberly-Clark's margins and bottom line in recent financial reports, but it has nonetheless continued to generate consistent revenue growth and profitability. Kimberly-Clark's resilient business can drive growth even in a changing macro environment, which makes the consumer staples stock a worthwhile addition to the long-term income investor's portfolio.